	A machine learning-guided epithelial plasticity score refines prognostication and immune-context stratification in muscle-invasive bladder cancer. Discov Oncol Yu D, Zhang Y, Tang J, Qing J, Hu K, Zhang J. PMID: 42440183 [PubMed - as supplied by publisher]
	Autophagy Stress Responses in Localized Prostate Cancer: A Flux-Aware Framework for Disease-Relevant Interpretation. Cells Hernández-Ramírez ZE, Malagón EMC, Puente-Rivera J, Flores-Estrada J. PMID: 42439611 [PubMed - indexed for MEDLINE]
	Prostate Club-like Cells Reveal Context-Dependent Epithelial States in Homeostasis Remodeling and Cancer. Cells Tang S, Wang X, Fogarty K, Chen F, Li K, Zhang M, Fu M, Li B. PMID: 42439610 [PubMed - indexed for MEDLINE]
	Integrative analysis prioritizes proteins associated with renal cell carcinoma and its risk factors. JNCI Cancer Spectr Sajal IH, Song AJ, Brown KM, Machiela MJ, Kraft P, Chanock S, Purdue MP, Dutta D. PMID: 42439544 [PubMed - as supplied by publisher]
	Development of a Novel (68)Ga-Labeled Radiotracer Targeting Carbonic Anhydrase IX for the Diagnosis of Clear Cell Renal Cell Carcinoma. Mol Pharm Liu T, Xu H, Chen X, Cui K, Zhou J, Cai L, Wang Y, Zhang J, Yang X, Gong K. PMID: 42439293 [PubMed - as supplied by publisher]
	Targeting the tumor microenvironment in genitourinary cancers: current progress and future directions in prostate cancer. Expert Opin Biol Ther Slovin SF. PMID: 42439176 [PubMed - as supplied by publisher]
	Robotic intracorporeal modified Bordeaux versus Padua ileal bladder: head-to-head surgical technique, perioperative and functional outcomes. Minerva Urol Nephrol Mastroianni R, Tuderti G, Anceschi U, Bove AM, Brassetti A, D'Annunzio S, Ferriero M, Flammia RS, Misuraca L, Proietti F, Licari L, Bologna E, Chiacchio G, Guaglianone S, Leonardo C, Simone G. PMID: 42438988 [PubMed - indexed for MEDLINE]
	Assessing the concordance between ChatGPT-4 and EAU guidelines indications in bladder cancer management: a real-world study. Minerva Urol Nephrol Lo Re M, Cadenar A, Pezzoli M, Mancon S, Fuligni E, Lambertini L, Carlino A, Catanzaro R, DI Dio M, Minervini A, Cocci A. PMID: 42438987 [PubMed - indexed for MEDLINE]
	Preliminary feasibility of SHURUI single-port robot-assisted radical cystectomy with exploratory comparison to a contemporaneous da Vinci Xi single-port cohort. Minerva Urol Nephrol Zhu Q, Wang J, Wei Y, Liu W, Shen L, Fankhauser CD, Gu M. PMID: 42438984 [PubMed - indexed for MEDLINE]
	Off-clamp and on-clamp robotic-assisted partial nephrectomy in ischemia-sensitive patients: a multicenter propensity score-matched study (RAPN OFF-CLAMP study - UroCCR 187). Minerva Urol Nephrol Schurdi-Levraud L, Margue G, Geshkovska A, Bensalah K, Ricolleau C, Bruyere F, Champy C, Michel C, Surlemont L, Fantoni JC, Fontenil A, Sarrazin C, Beauval JB, Parier B, Panthier F, Patard JJ, Belas O, Bigot P, Bernhard JC. PMID: 42438983 [PubMed - indexed for MEDLINE]
	First report of safety and outcomes of radiofrequency ablation of renal tumors using a new automated energy delivery-controlled system. Minerva Urol Nephrol Ferrillo G, Baldassarre E, Sirugo T, Romano S, Lanza E, Poretti D, Saita A, Levi R, Lughezzani G, Buffi NM, Casale P, Francone M, Pedicini V. PMID: 42438982 [PubMed - indexed for MEDLINE]
	Perioperative safety and short-term survival outcomes of radical nephrectomy with thrombectomy in geriatric renal cell carcinoma patients with venous tumor thrombus. Minerva Urol Nephrol Guan Y, Hong P, Xiao R, Tang S, Liu Z, Tian X, Wang G, Ma L, Zhang H, Zhang S. PMID: 42438981 [PubMed - indexed for MEDLINE]
	YAU-RCC spotlight: where evidence ends and consensus begins for renal cell carcinoma. Insights from the Advanced Urologic Cancer Consensus Conference (AUC3) 2025. Minerva Urol Nephrol Mollica V, Yekedüz E, Amparore D, Campi R, European Association of Urology (EAU) Young Academic Urologists (YAU) Renal Cancer Working Group. PMID: 42438977 [PubMed - in process]
	Incidence and Spectrum of Adverse Events With Enfortumab Vedotin Therapy in Advanced or Metastatic Urothelial Carcinoma: Evidence From a Systematic Review and Meta-Analysis. Arch Esp Urol Li X, Leng W, Hu W, Gao D, Zhu Z, Lin J, Xu C. PMID: 42438880 [PubMed - indexed for MEDLINE]
	Age as a Predictor of Prostate Cancer Risk Stratification in Systematic Prostate Biopsy. Arch Esp Urol Bostanci C, Erdem K. PMID: 42438876 [PubMed - indexed for MEDLINE]
	Survival in Synchronous Versus Metachronous Bladder and Prostate Cancer. Arch Esp Urol Yalç, Tuncay E, Arslan S, Araci HE, Köseo. PMID: 42438875 [PubMed - indexed for MEDLINE]
	Radiologic and Lipid Metabolism Imaging Features Associated with FABP2 Expression in Clear Cell Renal Cell Carcinoma: An Interpretable Supervised Machine Learning Radiogenomic Study. Arch Esp Urol Greco F, Cataldo M, Panunzio A, Tafuri A, Beomonte Zobel B, Mallio CA. PMID: 42438874 [PubMed - indexed for MEDLINE]
	Immunohistochemistry-Based Molecular Subtyping in Muscle-Invasive Bladder Cancer: Predicting Response to Neoadjuvant Chemotherapy. Arch Esp Urol Pérez-Bartivas L, Leiva-Cepas F, Ponferrada D, Flores-Paco P, Atance-Morales V, Martínez M, Armenta-Triviño A, Rodríguez-Alonso RM, De La Haba-Rodríguez J, Aranda E, Méndez-Vidal MJ. PMID: 42438872 [PubMed - indexed for MEDLINE]
	Magnetic Resonance Imaging as a Predictor of Early Discontinuation of Active Surveillance in Patients with Prostate Cancer. Arch Esp Urol Domínguez Argomedo R, de Pablos-Rodríguez P, Pelechano Gómez P, Martín García MI, Arrizabalaga Solano A, Rodríguez Part V, Beamud Cortés M, Calatrava Fons A, Gutiérrez Castañé C, Gómez-Ferrer Lozano Á, García Cortés Á, López Gonzalez JA, Domínguez Escrig JL, Romero Hinostroza C, Sánchez Aparisi E, Casanova Ramón-Borja J. PMID: 42438871 [PubMed - indexed for MEDLINE]
	Androgen Deprivation Therapy and Cardiovascular Health: Challenges and Opportunities in Prostate Cancer Care. Arch Esp Urol Fernández Alonso S, López Campos F, Büchser D, Guardado S, Andreescu J, Vásquez W, Castaño A, Gil Moradillo J, García González L, Loblaw A, Couñago F. PMID: 42438869 [PubMed - indexed for MEDLINE]

Articles 1 - 20 / 179959

Page 1 of 8998



		Time frame

	Mediscope AG E-mail: info@mediscope.ch
	Disclaimer \| Privacy Policy